AbbVie Inc.
AbbVie Inc. (ABBV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABBV · as of Jun 8, 2026
Key Statistics
Explore AbbVie Inc. Data
abbv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 41 · Buy rate: 68.3%
The ABBV analyst consensus is Buy, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month price target is $257.54, representing +13.34% upside from the current price of $227.23.
Competitors & Peers
abbv competitorsABBV
AMGN
AZN
GILD
JNJ
MRKStock Performance
Full HistoryAbout AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's dise…
what is abbvie inc. · abbv stock overview · abbvie inc. company profile · who is abbvie inc. ceo · abbv NYSE · abbvie inc. headquarters · abbvie inc. business segments
About Stock Overview & Key Data
AbbVie Inc. (ABBV) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Jan 2, 2013. As of the latest trading session, ABBV stock price is $227.23, with a market capitalization of $401.5B. The stock has returned +20.13% over the past 12 months and -0.55% year-to-date.
According to 41 Wall Street analysts, the consensus rating for AbbVie Inc. stock is Buy, with an average 12-month price target of $257.54. In fiscal year 2025, AbbVie Inc. reported revenue of $61.2B and net income of $4.2B. For detailed data — including AbbVie Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AbbVie Inc. (ABBV) stock price is $227.23. The stock is traded on NYSE under the ticker symbol ABBV. The 52-week range is $181.73 – $244.81.